Company intelligence / Profile preview

Centre for Virology, Vaccinology and Therapeutics

HONG KONG / Pak Shek Kok / Sha Tin District, Hong Kong SAR Chinacvvt.hk ↗
Ownership
Private
Employees
~75
Development stage
Preclinical
01

Overview

CVVT has established itself as a leading translational research center focused on infectious disease control through the development of rapid diagnostics, broad-spectrum antivirals, novel vaccines—including a nasal spray H5N1 avian flu vaccine—and enabling technology platforms. The center has demonstrated success in culturing previously uncultivable human rhinovirus C using innovative organoid models and is actively advancing multiple programs toward clinical application.

Therapeutic areas
Infectious Diseases
Modalities
Vaccines (including live attenuated viral vectors, mRNA)Monoclonal antibodies (bi-specific neutralizing antibodies)Small molecules/broad-spectrum antiviralsDiagnostics (multiplex diagnostic tests)
Industry
Academic Hospital/University/Research
02

Drug pipeline

1 asset

IBIS

Pre-clinical
Indications
COVID-19, SARS-CoV-1 infection, SARS-CoV-2 infection
03

Partnerships

Collaborates with HKU Department of Microbiologypartnerships with overseas institutes via program leaderspart of global consortia developing COVID‑19 vaccines.

Beyond the preview

Go deeper on Centre for Virology, Vaccinology and Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centre for Virology, Vaccinology and Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call